Drug Target Review

SEPTEMBER 10, 2024

The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. In recent years, the biopharmaceutical industry has identified rapid Toxicology (Tox) material supply as the new critical path to IND readiness.

Drug Development 64

Drug Development Clinical Supply Production FDA 64

The Premier Consulting Blog

OCTOBER 26, 2022

Early development and first-in-human In the early stages of drug development, process and chemistry, manufacturing, and controls (CMC) knowledge may be limited. Thus, a single GMP batch may be the extent of process knowledge at scale at the time of an Investigational New Drug application (IND) submission.

Production 40

Production Assay Development Clinical Supply Engineering 40

The Pharma Data

OCTOBER 27, 2020

The collaboration aims to leverage Molecular Partners’ proprietary DARPin® technologies and Novartis’ broad expertise in global drug development, regulatory affairs, manufacturing and commercialization to rapidly advance the program in keeping with the unprecedented global urgency created by the pandemic.

Therapies 40

Therapies Virus Treatment Clinical Trials 40